Volume : 09, Issue : 10, October – 2022

Title:

87.DRUG UTILIZATION REVIEW OF ORAL HYPOGLYCEMIC DRUGS: A RETROPROSPECTIVE STUDY
‬

Authors :

Asma Bader*, Syeda Lubna Eram, Fareeha Qureshi, Syeda Zehra Fatima

Abstract :

A drug utilization review of a population’s drug use to determine effectiveness, potential risks, drug interaction issues, and other issues. It aims to give doctors recommendations for the rational use of drugs, reducing side effects, polypharmacy, and exposure to potent drugs. With this study, we hope to provide a basic understanding of the illness and draw attention to the fact that improper use of anti-diabetic medications can result in poor patient outcomes and significant wastage of money and resources. Background: In recent years, India has seen a rapidly exploding epidemic of diabetes, and it presently holds the world record for having the most diabetic people in one nation. In view of this situation, drug utilization review of anti-diabetic medicines in the Indian healthcare environment has a valid significance to promote rational drug use in diabetics. Objective: This study aimed to identify the demographic information about the patients and to examine prescription trends for antidiabetic medications, as well as the distribution of adverse drug reactions, diabetes complications, and co-occurring diseases. Methodology: A retrospective observational study was conducted. Conclusion: The use of anti-diabetic drugs was almost found to be rational. The Pharmacist is the key person for improved therapeutic management based on the stage and condition of the patient.
Keywords: Drug Utilization, Prescription Pattern, Insulin, Hypertension, Anti-diabetic drugs.

Cite This Article:

References:

1. “Diabetes Fact Sheet N°312″. WHO. October 20133.Archived from the original on 26 August 2013. Retrieved 25 March 2014.
2. WHO official website: https://www.who.int/health-topics/hypertension#tab=tab_1
3. “The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure,” National Heart, Lung and Blood Institute, December 2002, NIH Publication no. 03-5233.
4. Chiang JL, Kirkman MS, Laffel LM, Peters AL (July 2014). “Type 1 diabetes through the life span: a position statement of the American Diabetes Association”. Diabetes Care. 37 (7): 2034-54. doi: 10.2337/dc14-1140. PMC 5865481. PMID 24935775
5. Shoback DG, Gardner D, eds. (2011). “Chapter 17”. Greenspan’s basic & clinical endocrinology (9th ed.). New York: McGraw-Hill Medical. ISBN 978-0-07-162243-1.
6. Artificial pancreas. JDRF. http://www.jdrf.org/research/artificial-pancreas/. Accessed March 11, 2018.
7. Natural medicines in the clinical management of diabetes. Natural Medicines. http://naturalmedicines.therapeuticresearch.com. Accessed March 6, 2018.
8. Morrow ES. AllscriptsEPSi. Mayo Clinic. Aug. 19, 2020.
9. Papadakis MA, et al., eds. Diabetes mellitus and hypoglycemia. In: Current Medical Diagnosis & Treatment 2018. 57th ed. New York, N.Y.: McGraw-Hill Education; 2018. http://accessmedicine.mhmedical.com. Accessed March 6, 2018.
10. Gabbe SG, et al. Diabetes mellitus complicating normal pregnancy. In: Obstetrics: Normal and Problem Pregnancies. 7th ed. Philadelphia, Pa.: Sauders Elsevier; 2017. http://www.clinicalkey.com. Accessed Jan. 10, 2018.
11. Cunningham FG, et al. Diabetes mellitus. In: Williams Obstetrics. 24th ed. New York, N.Y.: The McGraw-Hill Companies; 2014. http://accessmedicine.mhmedical.com. Accessed March 6, 2018.